STOCK TITAN

Natera to Webcast Live Presentation at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Rhea-AI Summary

Natera, a leader in cell-free DNA testing, will webcast a live presentation at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at 12:40 p.m. PT. CEO Steve Chapman and CFO Mike Brophy will discuss the company's recent business activities and provide an overview, followed by a Q&A session. Investors can access the live presentation and archived content on investor.natera.com. Natera aims to transform disease management worldwide, focusing on women's health, oncology, and organ health.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction

+3.87%
1 alert
+3.87% News Effect

On the day this news was published, NTRA gained 3.87%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SAN CARLOS, Calif., Jan. 5, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will webcast a live presentation at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2021 at 12:40 p.m. PT (3:40 p.m. ET).

Steve Chapman, Chief Executive Officer, and Mike Brophy, Chief Financial Officer, will provide an overview of the company and discuss recent business activities, followed by a question and answer session.

Access to the live webcast and subsequent archived presentation will be available at investor.natera.com.

About Natera
Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn.

Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 650-249-9090
Media: Paul Greenland, VP of Corporate Marketing, Natera, Inc., pr@natera.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/natera-to-webcast-live-presentation-at-the-39th-annual-jp-morgan-healthcare-conference-301200747.html

SOURCE Natera, Inc.

FAQ

When is Natera's presentation at the J.P. Morgan Healthcare Conference?

Natera's presentation is scheduled for January 12, 2021, at 12:40 p.m. PT.

Who will represent Natera at the J.P. Morgan Healthcare Conference?

CEO Steve Chapman and CFO Mike Brophy will represent Natera at the conference.

Where can I watch the Natera webcast?

The webcast can be accessed at investor.natera.com.

What will Natera discuss at the healthcare conference?

Natera will provide an overview of the company and discuss recent business activities.

What is Natera's focus area in cell-free DNA testing?

Natera focuses on women's health, oncology, and organ health.
Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

29.37B
134.35M
3.2%
96.35%
2.7%
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN